Literature DB >> 15761696

Glutamate receptor subtypes: promising new pharmacotherapeutic targets.

Guy A Higgins, Klaus A Miczek.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15761696     DOI： 10.1007/s00213-005-2246-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  11 in total

Review 1.  NMDA receptor pathways as drug targets.

Authors:  John A Kemp; Ruth M McKernan
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

2.  Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7.

Authors:  John F Cryan; Peter H Kelly; Hans C Neijt; Gilles Sansig; Peter J Flor; Herman van Der Putten
Journal:  Eur J Neurosci       Date:  2003-06       Impact factor: 3.386

Review 3.  Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.

Authors:  James N C Kew
Journal:  Pharmacol Ther       Date:  2004-12       Impact factor: 12.310

4.  Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.

Authors:  J A Monn; M J Valli; S M Massey; M M Hansen; T J Kress; J P Wepsiec; A R Harkness; J L Grutsch; R A Wright; B G Johnson; S L Andis; A Kingston; R Tomlinson; R Lewis; K R Griffey; J P Tizzano; D D Schoepp
Journal:  J Med Chem       Date:  1999-03-25       Impact factor: 7.446

5.  2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.

Authors:  F Gasparini; K Lingenhöhl; N Stoehr; P J Flor; M Heinrich; I Vranesic; M Biollaz; H Allgeier; R Heckendorn; S Urwyler; M A Varney; E C Johnson; S D Hess; S P Rao; A I Sacaan; E M Santori; G Veliçelebi; R Kuhn
Journal:  Neuropharmacology       Date:  1999-10       Impact factor: 5.250

6.  Glutamate stimulates inositol phosphate formation in striatal neurones.

Authors:  F Sladeczek; J P Pin; M Récasens; J Bockaert; S Weiss
Journal:  Nature       Date:  1985 Oct 24-30       Impact factor: 49.962

Review 7.  Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders.

Authors:  W Spooren; T Ballard; F Gasparini; M Amalric; V Mutel; R Schreiber
Journal:  Behav Pharmacol       Date:  2003-07       Impact factor: 2.293

8.  The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

Authors:  E H Wong; J A Kemp; T Priestley; A R Knight; G N Woodruff; L L Iversen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate.

Authors:  N A Anis; S C Berry; N R Burton; D Lodge
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

10.  Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor.

Authors:  A-M Linden; B G Johnson; S C Peters; H E Shannon; M Tian; Y Wang; J L Yu; A Köster; M Baez; D D Schoepp
Journal:  Neuropharmacology       Date:  2002-08       Impact factor: 5.250
View more
  2 in total

Review 1.  Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies.

Authors:  Matthias E Liechti; Athina Markou
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

2.  The repertoire of G protein-coupled receptors in the sea squirt Ciona intestinalis.

Authors:  N Kamesh; Gopala K Aradhyam; Narayanan Manoj
Journal:  BMC Evol Biol       Date:  2008-05-01       Impact factor: 3.260
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.